Atlas Crest Investment Corp II
NYSE:ACII
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
US |
Atlas Crest Investment Corp II
NYSE:ACII
|
434.3m USD | -201 | ||
CA |
A
|
Advance Lithium Corp
XTSX:AALI
|
549.1B CAD | -846 376.9 | |
US |
V
|
Viveon Health Acquisition Corp
NYSE-MKT:VHAQ
|
332.4B USD | -140 273.7 | |
US |
G
|
Gould Investors LP
OTC:GDVTZ
|
304.4B USD | 0 | |
US |
C
|
Carson Energy Development Corp
OTC:CDVM
|
270.6B USD | -77 926.9 | |
NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
76.5B Zac | 0 | |
US |
Liberty Bancshares Inc
OTC:LBSI
|
55.5B USD | 0 | ||
US |
Ergo Science Corp
OTC:ERGN
|
55.2B USD | -10 816.3 | ||
US |
H
|
HK Graphene Technology Corp
OTC:HKGT
|
53.9B USD | -34 818.3 | |
ID |
Amman Mineral Internasional Tbk PT
IDX:AMMN
|
692.5T IDR | 28 | ||
US |
Coupang Inc
F:788
|
37.4B EUR | 47.5 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.